The 50 dispensaries licensed to sell recreational marijuana in Nevada have experienced a 20%-30% decline in sales since an initial explosion of activity on July 1, according to a report by the Nevada Department of Taxation.
The tax department said the drop in sales stem from the dispensaries’ inability to meet demand, according to the Reno Gazette-Journal.
Governors in at least two states that have legalized recreational marijuana are pushing back against the Trump administration and defending their efforts to regulate the industry.
Alaska Gov. Bill Walker, a former Republican, sent a letter to U.S. Attorney General Jeff Sessions this week asking the Department of Justice to maintain the Obama administration’s more hands-off enforcement approach to states that have legalized the drug.
The letter comes after Sessions sent responses recently to the governors of Alaska, Colorado, Oregon and Washington state after they asked the attorney general to allow the cannabis experiments to continue in the first four
Washington state recently eased restrictions on how many producer licenses marijuana businesses can own, a move that could lead to more competition, an uptick in mergers and acquisitions and possibly increased supply.
Under the state’s revised policy, business owners can up their licenses from one to three, effective immediately.
Telstra is utilising its 'deep, deep skills in cyber' by launching security operations centres in Sydney, Melbourne, and across the globe, as well as likely upgrading its existing facility in Canberra.
The Canadian holder of a license to cultivate medical marijuana in Florida plans to expand its production capacity in the state by more than 35 times to capitalize on the launch of the Sunshine State’s full-fledged MMJ market.
Liberty Health Sciences., which is based in Toronto and trades on the Canadian Securities Exchange under the symbol LHS, will purchase 36 acres of land in Alachua County, Florida, for $866,975 in cash, the company announced in a news release.
The parcel is adjacent to the company’s existing 13,000-square-foot grow facility at Chestnut Hill Tree Farm, which produces 700 kilograms (about
Maine officials say the state won’t be able to meet its February deadline to allow recreational marijuana sales.
Republican State Sen. Roger Katz said the agencies responsible for the recreational market rollout don’t have sufficient time before the deadline to perform such tasks as licensing growers, writing departmental rules and hiring new inspectors, the Portland Press Herald reported.
The president of Legalize Maine estimates the delay means adult-use business licenses won’t be issued until summer 2018.
Advocates for legalization say the delay “keeps the black market going.”
The adult-use marijuana program voters legalized in November 2016 already has been
One of Canada’s largest licensed medical marijuana producers doubts all the provinces will have networks of retail MJ stores ready for takeoff when the country legalizes recreational cannabis next summer – and so the company is readying its own mail-order platform.
Canopy Growth believes the majority of its sales in the first two years of the recreational market will be conducted through a mail-order system, the company said in a management document released Monday with its financial results.
Consequently, Canopy said it took steps in the first half of this year to prepare an “Amazon-like” online marketplace to
The DEA’s move a year ago was hailed as a small step in the right direction, since the federal government for decades has blocked any kind of scientific research into possible medicinal benefits of cannabis.
According to The Washington Post, the DOJ has “effectively blocked the (DEA) from taking action on more than two dozen requests to grow marijuana
Aphria is increasing its stake in the booming cannabinoid-based extracts market with an 11.5 million Canadian dollar ($9 million) investment in Scientus Pharma, a vertically integrated biopharmaceutical company.
Toronto-based Scientus Pharma conducts research and product development related to medical cannabinoids and their derivatives. The investment is in the form of senior, secured convertible debt.
Aphria (Toronto Stock Exchange: APH), based in Leamington, Ontario, said the investment also gives it access to Scientus’ so-called dealer’s license. The holder of such a license is permitted to buy, process and sell cannabinoid derivatives in international markets.